A Study of LY2940680 in Japanese Participants With Advanced Cancers
Status:
Completed
Trial end date:
2017-06-28
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the safety and tolerability of LY2940680 up to
the global recommended dose in Japanese participants with advanced solid cancers.